Literature DB >> 14615153

Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis.

Jun Namikoshi1, Shigeo Otake, Satomi Maeba, Mitsuo Hayakawa, Yoshimitsu Abiko, Masafumi Yamamoto.   

Abstract

In this study, we have assessed the efficacy of the 40-kDa outer membrane protein (40k-OMP) of Porphyromonas gingivalis as a nasal vaccine for the prevention of adult periodontitis. Mice nasally immunized with 40k-OMP and cholera toxin as mucosal adjuvant displayed significant levels of 40k-OMP-specific serum IgG1, IgG2b and IgA as well as mucosal IgA antibodies (Abs) in saliva and nasal secretions. Ab-forming cell (AFC) analysis confirmed the antibody titers by detecting high numbers of 40k-OMP-specific AFCs in spleen, salivary glands and nasal passages. Because 40k-OMP-specific IgG inhibited coaggregation of P. gingivalis vesicles and S. gordonii, it may be an important tool for the prevention of adult periodontitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615153     DOI: 10.1016/s0264-410x(03)00576-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.

Authors:  Chenlu Liu; Tomomi Hashizume; Tomoko Kurita-Ochiai; Kohtaro Fujihashi; Masafumi Yamamoto
Journal:  Mol Oral Microbiol       Date:  2010-06       Impact factor: 3.563

2.  Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.

Authors:  Y Koizumi; T Kurita-Ochiai; S Oguchi; M Yamamoto
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

3.  Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies.

Authors:  Fumiki Momoi; Tomomi Hashizume; Tomoko Kurita-Ochiai; Yoshikazu Yuki; Hiroshi Kiyono; Masafumi Yamamoto
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

4.  Induction of antibody response in the oral cavity of dogs following intraocular (eye drop) immunization with Porphyromonas gingivalis cell lysate incorporated in pH-sensitive fusogenic polymer-modified liposomes.

Authors:  Yosuke Shimizu; Tadashi Iwasaki; Tomoko Tajima; Eiji Yuba; Kenji Kono; Shinobu Watarai
Journal:  J Vet Med Sci       Date:  2016-12-05       Impact factor: 1.267

5.  Atheroprotective nasal immunization with a heat shock protein 60 peptide from Porphyromonas gingivalis.

Authors:  Ji-Young Joo; Gil-Sun Cha; Hyun-Joo Kim; Ju-Youn Lee; Jeomil Choi
Journal:  J Periodontal Implant Sci       Date:  2020-05-22       Impact factor: 2.614

6.  Anti-atherosclerotic vaccination against Porphyromonas gingivalis as a potential comparator of statin in mice.

Authors:  Hyun-Su Ha; Tae Young Kim; Soo Jung Han; Hak-Joon Sung; Kyoung Yul Seo; Jong-Won Ha
Journal:  PeerJ       Date:  2021-04-20       Impact factor: 2.984

Review 7.  Mucosal Vaccination Against Periodontal Disease: Current Status and Opportunities.

Authors:  Victor Vaernewyck; Boaz Arzi; Niek N Sanders; Eric Cox; Bert Devriendt
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.